NCT07480902Recruiting
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Study To Compare The Efficacy Of Cervical Cytology With Molecular Screening For Detecting Reactive Cellular Changes In The Cervix In An Open Population
Source: ClinicalTrials.gov · Last updated 18 Mar 2026
Brief summary (registry, in English)
This study compares how effective is the molecular screening (a blood test) using Pap smear as reference, that is, a comparison of these tests abilities to detect precursor lesions and cervical cancer among women of an open population
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 558 (estimated)
- First submitted
- 13 Mar 2026
- Start date
- 3 Feb 2026
- Primary completion date
- Apr 2026
- Lead sponsor
- Timser SAPI de CV
- Diseases
- Cervical cancer
- NCT number
- NCT07480902
What you commit to
- Study type: Interventional
- Planned participants: 558
- From 3 Feb 2026 to the primary completion date, Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Being under oncological treatment (chemotherapy, radiotherapy and/or brachytherapy).
- Have a previous confirmatory diagnosis of HIV and/or hepatitis infection.
- Having taken antiplatelet medications, e.g., acetylsalicylic acid, at least 24 hours before the study.
- Discontinuation Criteria:
Other
- Having a subtotal, total, or radical hysterectomy.
- Being pregnant or suspected of being pregnant. A rapid urine test will be performed. If the result is positive, the patient will be excluded from the protocol and referred for prenatal care.
- Being on their period.
- If the participant refuses any of the study procedures.
- If the study gynecologist detects that the participant has had a hysterectomy.
- If the volume of the biological samples is insufficient for testing.
Who the study is looking for
- Be in good general health.
- Age 18-85 years.
- A minimum fast of 6 hours and no more than 12 hours.
- Refrain from sexual intercourse 24 hours before the study.
- Give written informed consent.
Age in the registry: 18 years to 85 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Consultorio Médico TIMSER Coordinator of this site? Confirm its status | Mexico City | Mexico | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.